Cancer stem cells in head and neck squamous cell carcinoma: A review

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 10, 2013, Pages 5579-5587

  Satpute, Pranali Shirish ^a   Hazarey, Vinay ^a   Ahmed, Riyaz ^b   Yadav, Lalita ^c  

^a GOVERNMENT DENTAL COLLEGE AND HOSPITAL   (India)

^b Government Medical College   (India)

^c Department of Oral Medicine and Radiology Kalka Dental College Hospital and Research Centre   (India)

Author keywords

Cancer stem cells; Epithelial; Head and neck squamous cell carcinoma; Mesenchymal transition

Indexed keywords

CANCER STEM CELL; DISEASE COURSE; HEAD AND NECK TUMOR; HUMAN; METASTASIS; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE;

CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS;

EID: 84890528570     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.10.5579     Document Type: Short Survey

References (89)

1. Al-Hajj M, Wicha M, Benito-Hernandez A, et al (2003). Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA, 100, 3983-8.
2. Allegra E, Garozzo A, Lombardo N, et al (2006). Mutations and polymorphisms in mitochondrial DNA in head and neck cancer cell lines. Acta Otorhinolaryngol Ital, 26, 185-90.
3. Allegra E, Baudi F, La Boria A, et al (2009). Multiple head and neck tumours and their genetic relationship. Acta Otorhinolaryngol Ital, 29, 237-41.
4. Allegra E, Trapasso S (2012). Cancer stem cells in head and neck cancer. Onco Targets and Therapy, 5, 375-83.
5. Batlle E, Sancho E, Franci C, et al (2000). The transcription factor snail is a repressor of E-cadherin gene expression in the epithelial tumour cells. Nat Cell Biol, 2, 84-9.
6. Baumann M, Krause M (2010). CD44: a cancer stem cell-related biomarker with predictive potential for radiotherapy. Clin Cancer Res, 16, 5091-3.
7. Bonnet D, Dick J (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med, 3, 730-7.
8. Borovski T, De Souza E, Melo F, et al (2011). Cancer stem cell niche: the place to be. Cancer Res, 71, 634-9.
9. Bosron W, Lumeng L, Li T (1988). Genetic polymorphism of enzymes of alcohol metabolism and susceptibility to alcoholic liver disease. Mol Aspects Med, 10, 147-58.
10. Braakhuis B, Tabor M, Leemans C, et al (2002). Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck, 24, 198-206.
11. Braakhuis B, Leemans C, BrakenhoffRH, et al (2005). Expanding fields of genetically altered cells in head and neck squamous carcinogenesis. Semin Cancer Biol, 15, 113-20.
12. Califano J, Westra W, Meininger G, et al (2000). Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res, 2, 347-52.
13. Cano A, Pérez-Moreno M, Rodrigo I, et al (2000). The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol, 2, 76-83.
14. Carvalho A, Nishimoto I, Califano J, et al (2005). Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer, 114, 806-16.
15. Chen C, Wei Y, Hummel M, et al (2011). Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS One, 6, 16466.
16. Chen Y, Chen Y, Hsu H, et al (2009). Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun, 385, 307-13.
17. Cheng G, Chan J, Wang Q, et al (2007). Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion and resistance to paclitaxel. Cancer Res, 67, 1979-87.
18. Chikamatsu K, Ishii H, Takahashi G, et al (2012). Resistance to apoptosis-inducing stimuli in CD44+ head and neck squamous cell carcinoma cells. Head Neck, 34, 336-43.
19. Chiou S, Yu C, Huang Y, et al (2008). Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high grade oral squamous cell carcinoma. Clin Cancer Res, 14, 4085-95.
20. Clarke M, Dick J, Dirks P, et al (2006). Cancer stem cells: Perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res, 66, 9339-44.
21. Cohnheim J (1875). Congenitales, quergestreiftes muskelsarkon der nireren. Virchows Arch, 65, 64.
22. Collins A, Berry P, Hyde C, et al (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res, 65, 10946-51.
23. Dalerba P, Dylla S, Park I, et al (2007). Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA, 104, 10158-63.
24. Davis S, Divi V, Owen J, et al (2010). Metastatic potential of cancer stem cells in head and neck squamous cell carcinoma. arch otolaryngol. Head Neck Surg, 136, 1260-6.
25. Durante F (1874). Nessus pathophysiological between the flaw structure of the mother and the genesis of some malignant tumors. Arch Memor Observ Chir Prat, 111, 217.
26. Eramo A, Lotti F, Sette G, et al (2008). Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ, 15, 504-14.
27. Fang D, Nguyen T, Leishear K, et al (2005). A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res, 65, 9328-37.
28. Fuchs E, Tumbar T, Guasch G (2004). Socializing with the neighbours: stem cells and their niche. Cell, 116, 769-78.
29. Garozzo A, Cutrona D, Palmeri S, et al (1999). The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma. Acta Otorhinolaryngol Ital, 19, 342-7.
30. Ginestier C, Hur M, Charafe-Jauffret E, et al (2007). ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell, 1, 555-67.
31. Hermann P, Huber S, Herrler T, et al (2007). Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell, 1, 313-23.
32. Hirschmann-Jax C, Foster A, Wulf G, et al (2004). A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA, 101, 14228-33.
33. Isacke C, Yarwood H (2002). The hyaluronan receptor, CD44. Int J Biochem Cell Biol, 34, 718-21.
34. Iwatsuki M, Mimori K, Yokobori T, et al (2010). Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci, 101, 293-9.
35. Jemal A, Bray F, Center M, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
36. Joshua B, Kaplan M, Doweck I, et al (2012). Frequency of cells expressing CD44,ahead and neck cancer stem cell marker: correlation with tumor aggressiveness. Head Neck, 34, 42-9.
37. Kajita M, Itoh Y, Chiba T, et al (2001). Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol, 153, 893-904.
38. Kalluri R, Neilson E (2003). Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest, 112, 1776-84.
39. Kalluri R, Weinberg R (2009). The basics of epithelialmesenchymal transition. J Clin Invest, 119, 1420-8.
40. Koukourakis MI, Giatromanolaki A, Tsakmaki V, et al (2012). Cancer stem cell phenotype relates to radiochemotherapy out come in locally advanced squamous cell head-neck cancer. Br J Cancer, 106, 846-53.
41. Krishnamurthy S, Dong Z, Vodopyanov D, et al (2010). Endothelial cell-initiated signalling promotes the survival and self renewal of cancer stem cells. Cancer Res, 70, 9969-78.
42. Krishnamurthy S, Nor J (2012). Head and neck cancer stem cells. J Dent Res, 91, 334-40.
43. Kuhn N, Tuan R (2010). Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. J Cell Physiol, 222, 268-77.
44. Li Q, Xu J, Wang W, et al (2009). Twist1-mediated adriamycininduced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells. Clin Cancer Res, 15, 2657-65.
45. Lim S, Oh S (2005). The role of CD24 in various human epithelial neoplasias. Pathol Res Pract, 201, 479-86.
46. Lim Y, Oh S, Cha Y, et al (2011). Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas. Oral Oncol, 47, 83-91.
47. Mani S, Guo W, Liao M, et al (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 133, 704-15.
48. Morel A, Lièvre M, Thomas C, et al (2008). Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One, 3, 2888.
49. Moreno-Bueno G, Portillo F, Cano A (2008). Transcriptional regulation of cell polarity in EMT and cancer. Oncogene, 27, 6958-69.
50. Morrison S, Spradling A (2008). Stem cells and niches: Mechanisms that promote stem cell maintenance throughout life. Cell, 132, 598-611.
51. Neiva K, Zhang Z, Miyazawa M, et al (2009). Crosstalk initiated by endothelial cells enhances migration and inhibits anoikis of squamous cell carcinoma cells through STAT/Akt/ERK signaling. Neoplasia, 11, 583-93.
52. Nör J, Peters M, Christensen J, et al (2001). Engineering and characterization of functional human microvessels in immunodeficient mice. Lab Invest, 81, 453-63.
53. Nowell P (1976). The clonal evolution of tumor cell populations. Science, 194, 23-8
54. Okamoto A, Chikamatsu K, Sakakura K, et al (2009) Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck. Oral Oncol, 45, 633-9.
55. Park I, Morrison S, Clarke M (2004). Bmi-1, stem cells, and senescence regulation. J Clin Invest, 113, 175-9.
56. Perl A, Wilgenbus P, Dahl U, et al (1998). A causal role for Ecadherin in the transition from adenoma to carcinoma. Nature, 392, 190-3.
57. Pierce G, Dixon F, Verney E (1960). Teratocarcinogenic and tissue forming potentials of the cell types comprising neoplastic embryoid bodies. Lab Invest, 9, 583-602.
58. Prince M, Ailles L (2008). Cancer stem cells in head and neck squamous cell cancer. J Clin Oncol, 26, 2871-5.
59. Prince M, Sivanandan R, Kaczorowski A, et al (2007). Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA, 104, 973-8.
60. Reya T, Morrison S, Clarke M, et al (2001). Stem cells, cancer, and cancer stem cells. Nature, 414, 105-11.
61. Radisky D, LaBarge M (2008). Epithelial-mesenchymal transition and the stem cell phenotype. Cell Stem Cell, 2, 511-2.
62. Rasper M, Schäfer A, Piontek G, et al (2010). Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity. Neuro Oncol, 12, 1024-33.
63. Sánchez-Tilló E, Lázaro A, Torrent R, et al (2010). ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1. Oncogene, 29, 3490-500.
64. Singh S, Hawkins C, Clarke I, et al (2004). Identification of human brain tumour initiating cells. Nature, 432, 396-401.
65. Shook D, Keller R (2003). Mechanisms, mechanics and function of epithelialmesenchymal transition in early development. Mech Dev, 120, 1351-83.
66. Spivakov M, Fisher A (2007). Epigenetic signatures of stem-cell identity. Nat Rev Cancer, 8, 263-71.
67. Sun S, Wang Z (2011). Head neck squamous cell carcinoma c-Met+ cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis. Int J Cancer, 129, 2337-48.
68. Thiery J (2002). Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer, 2, 442-54.
69. Thiery J, Acloque H, YJ Huang R, et al (2009). Epithelialmesenchymal transitions in development and disease. Cell, 139, 871-90.
70. Thomasson H, Edenberg H, Crabb D, et al (1991). Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men. Am J Hum Genet, 148, 677-81.
71. Till J, McCulloch E (1961). A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res, 14, 213-22.
72. Valk-lingbeek M, Bruggeman S, Van Lohuizen M (2004). Stem cells and cancer; the polycomb connection. Cell, 118, 409-18.
73. Vlashi E, McBride W, Pajonk, F (2009). Radiation responses of cancer stem cells. J Cell Biochem, 108, 339-42.
74. Visus C, Ito D, Amoscato A, et al (2007). Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck. Cancer Res, 67, 10538-45.
75. Visvader J, Lindeman G (2008). Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer, 8, 755-68.
76. Wang S, Wong G, de Heer A, et al (2009). CD44 variant isoforms in head and neck squamous cell carcinoma progression. Laryngoscope, 119, 1518-30.
77. Whiteman E, Liu C, Fearon E, et al (2008). The transcription factor snail represses Crumbs3 expression and disrupts apico-basal polarity complexes. Oncogene, 27, 3875-9.
78. Widschwendter M, Fiegl H, Egle D, et al (2007). Epigenetic stem cell signature in cancer. Nat Genet, 39, 157-8.
79. Wollenberg B (2011). Implication of stem cells in the biology and therapy of head and neck cancer. GMS Curr Top Otolaryngol Head Neck Surg, 10.
80. Xia H, Cheung WK, Sze J, et al (2010). MiR-200a regulates epithelial-mesenchymal to stem-like transition via ZEB2 and β-catenin signaling. J Biol Chem, 285, 36995-7004.
81. Yang A, Fan F, Camp E (2006). Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res, 12, 4147-53.
82. Yang J, Mani S, Donaher J, et al (2004). Twist a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell, 117, 927-39.
83. Yang M, Wu M, Chiou S, et al (2008). Direct regulation of TWIST by HIF-1a promotes metastasis. Nat Cell Biol, 10, 295-305.
84. Yang M, Hsu D, Wang H, et al (2010). Bmi-1 is essential in twist1-induced epithelial-mesenchymal transition. Nat Cell Biol, 12, 982-92.
85. Zhang P, Zhang Y, Mao L, et al (2009). Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes. Cancer Lett, 277, 227-34.
86. Zhang Q, Shi S, Yen Y, et al (2010). A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Lett, 289, 151-60.
87. Zhang Z, Neiva K, Lingen M, et al (2010). VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2. Cell Death Differ, 17, 499-512.
88. Zhang Z, Filho M, Nor J (2012). The biology of head and neck cancer stem cells. Oral Oncol, 48, 1-9.
89. Zhou L, Wei X, Cheng L, et al (2007). CD133,one of the markers of cancer stem cells in Hep-2cell line. Laryngoscope, 117, 455-60.